✦ LIBER ✦

Concentration-effect and time-effect relationships of carteolol

✍ Scribed by T. Ishizaki; A. Ohnishi; T. Sasaki; K. Chiba; T. Suganuma; K. Kushida

Book ID: 104798335
Publisher: Springer
Year: 1983
Tongue: English
Weight: 1001 KB
Volume: 25
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00542514

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concentration-effect relationships for a

Concentration-effect relationships for antihypertensive drugs

✍ Peter A. Meredith 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Labetalol disposition and concentration-

Labetalol disposition and concentration-effect relationships during pregnancy.

✍ PC Rubin; L Butters; AW Kelman; C Fitzsimons; JL Reid 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 779 KB

The Variation in Slope of Concentration–

The Variation in Slope of Concentration–Effect Relationships

✍ Mathijs G.D. Smit; A. Jan Hendriks; John H.M. Schobben; Chris C. Karman; Henk P. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Time-dependent antihypertensive effect o

Time-dependent antihypertensive effect of carteolol—A beta-adrenoceptor antagonist with partial agonist activity

✍ Giles, Thomas D; Sander, Gary E; Kaneish, Ahmed; Quiroz, Antonio C 📂 Article 📅 1984 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

Pharmacokinetic and concentration-effect

Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension

✍ L. M. H. Wing; J. L. Reid; D. S. Davies; E. A. M. Neill; P. Tippett; C. T. Dolle 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 834 KB

Concentration-effect relationships of te

Concentration-effect relationships of tetrabenazine and dihydrotetrabenazine in the rat

✍ Reza Mehvar; Fakhreddin Jamali 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

To investigate the pharmacodynamics of tetrabenazine [1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2-H-benzo(a)quinol izine-2- one; 1], the drug of choice in the control of Huntington's chorea and tardive dyskinesia, and its major metabolite, dihydrotetrabenazine (2), ip doses of 3 mg/kg of the